Latest Human Genome Project (HGP) News

Bel Marra Health Supports a Recent Study Out of UCLA that Shows a Link Between Sugar and Brain HealthBel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that shows there is a tie between sugar and brain health. Toronto, ON (PRWEB) May 26, 2012 Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that shows there is a tie be...

Telomere Stability And Carcinogenesis: An Off-Again, On-Again RelationshipPrevious studies in mice have demonstrated antagonistic effects of telomerase loss on carcinogenesis. Telomere attrition can promote genome instability thereby stimulating initiation of early-stage cancers, but can also inhibit tumorigenesis by promo...

Pfizer's Inlyta, BI/Lilly's Jentadueto, Vertex' Kalydeco & NovoThirteen get CHMP nodsMedicines featuring on the European Medicines Agency's list of positive opinions from the May meeting of the Committee for Medicinal Products for Human Use (CHMP) included Pfizer's oral tyrosine kinase inhibitor Inlyta (axitinib) and Boehringer.....

CHMP recommends Medac's generic Zometa, clears infected MabThera, seeks harmonyThe EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended for approval German firm Medac's generic version of Novartis' Zometa (Zoledronic acid). The product, Zoledronic acid medac, is a concentrate solution for.....

Vertex's Cystic Fibrosis Drug Kalydeco Given Green Light By EU's Scientific Advisory PanelVertex's cystic fibrosis product Kalydeco is one of five new molecular entities given a positive opinion by Europe's Committee for Medicinal Products for Human Use on May 25, which also included Almirall's novel COPD therapy aclidinium and Novo Nordi...

Human medicines European Public Assessment Report (EPAR): Renagel, sevelamer, Revision: 19, Authorised

Human medicines European Public Assessment Report (EPAR): Pergoveris, follitropin alfa / lutropin alfa, Revision: 6, Authorised

Human medicines European Public Assessment Report (EPAR): Liprolog, insulin lispro, Revision: 14, Authorised

GenVec Reports Inducement AwardGAITHERSBURG, Md., May 25, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) announced today that on May 23, 2012 it granted an option to purchase shares of its common stock to Cynthia Collins, its newly appointed President and Chief Executive Officer. The option grant was approved by the Compensation Committee of GenVec's Board of Directors and the Board of Directors, and was ma...

Pfizers Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for ...

Structure of human protein critical for silencing genes solvedScientists have described the three-dimensional atomic structure of a human protein bound to a piece of RNA that "guides" the protein's ability to silence genes. The protein, Argonaute-2, is a key player in RNA interference, a powerful cellular pheno...

Franck's Pharmacy recalls sterile prescriptions from past 6 monthsFranck?s Compounding Pharmacy in Ocala, Fla., announced today that it is recalling all sterile human and veterinary prescriptions that is distributed from November 21, 2011, to May 21, 2012.

GSK receives positive opinion from European CHMP for pazopanib in the treatment of patients with certain advanced soft tissue sarcomasGlaxoSmithKline. plc (GSK) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for Votrient® (pazopanib) for the treatment of a...

New, more accurate test for paralytic shellfish poisonsFor decades, U.S. fisheries have tested the algal toxin levels of shellfish caught for human consumption by processing a sample of the shellfish in a blender and injecting the resulting slurry into the abdomen of live mice, causing them to suffer sei...

Researchers discover drug destroys human cancer stem cells but not healthy onesA team of scientists at McMaster has discovered that the drug thioridazine successfully kills cancer stem cells in humans while [...]

Tissue Regenix extends development partnership with NHS- updateAdds additional comments and share price Regenerative tissue specialist Tissue Regenix (LON:TRX) has agreed a major expansion of its development partnership with the NHS’s blood and transplant unit. The company, which has pioneered a technology...

News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 May 2012This page lists the opinions adopted at the May 2012 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes.

Emotions In Humans May Be Associated With Brain Cells Found In MonkeysA human's self-awareness is controlled by a small region in the brain called the anterior insular cortex (insula). Within the insula lies a unique cell type - the von Economo neuron (VEN) - believed to be unique to humans, elephants, whales and great...

New Drug For Destroying Human Cancer Stem CellsConventional cancer treatments, such as chemotherapy and radiation can cause toxic side-effects. Now, researchers have discovered that a drug called thioridazine can successfully destroy cancer stem cells in humans without these effects. Mick Bhatia,...

11 Scientists Funded to Move Arthritis Research ForwardEleven cutting-edge scientists researching arthritis have been awarded grants totaling $810,000 by the Arthritis National Research Foundation. Moving arthritis research forward with new, innovative ideas. Long Beach, CA (PRWEB) May 25, 2012 Eleven scientists researching arthritis were recently awarded grants totaling $810,000 by the Arthritis National Research Foundation. With 50 million America...

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinomaPfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adu...

News and press releases: European Medicines Agency confirms positive benefit-risk balance of MabTheraFollowing a quality review of the genetically engineered monoclonal antibody MabThera, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that the batches of the active substance of MabThera, rituxim...

Tissue Regenix extends development partnership with NHSRegenerative tissue specialist Tissue Regenix (LON:TRX) has agreed a major expansion of its development partnership with the NHS’s blood and transplant unit, NHSBT. The company, which has pioneered a technology that can swap worn out or damage...

A Modified Protocol to Maximize Differentiation of Human Preadipocytes and Improve Metabolic Phenotypes

European CHMP issues positive opinion to Vertex's KALYDECO for treatment of CFVertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (...

0 1 2 3 4 ›»

buy Human Genome Project (HGP) market research data and corporate reports now Advertisement